Advertisement

Document › Details
Bruker Corporation. (4/10/18). "Press Release: Bruker Launches New FT-IR R&D Spectrometer INVENIO". Munich.
![]() |
Region | München (Munich) |
Country | Germany | |
![]() |
Organisation | Bruker Corporation (Nasdaq: BRKR) |
Group | Bruker (Group) | |
Organisation 2 | Bruker Optics (Operating Business of Bruker Corporation) | |
Group | Bruker BioSciences (Group) | |
![]() |
Product | Invenio™ FT-IR R&D spectrometer |
Product 2 | Analytica 2018 München (Munich) | |
![]() |
Person | Müller, Michael (Bruker 201203 Marketing Manager at Bruker Optics) |
Person 2 | Minkova, Miroslava (Vertex 202303 Investor Relations formerly Bruker Corp 201611 Head of Investor Relations) | |
At Analytica 2018, Bruker today announces the launch of the new INVENIO™ Fourier Transform Infrared (FT-IR) research spectrometer. The INVENIO is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications.
The novel INVENIO combines many innovations with proven Vertex 70 technologies, such as unique FM technology for simultaneous mid and far IR spectroscopy. The new MultiTect™ technology allows for control of up to five internal detectors, covering the spectral range from far infrared to Vis/UV. A DigiTect™ detector slot enables additional flexibility for even more detectors. The smart INVENIO beam path further improves optical throughput and spectroscopic sensitivity.
In addition to performance and flexibility, a major goal of the INVENIO is to simplify the research user's experience. An integrated touch panel enables intuitive configuration set-ups and workflows for R&D applications, and the system can also be switched to notebook operation. The Transit™ channel allows for easy transmission measurements, without removing experiments from the sample compartment.
The INVENIO is an intelligent spectrometer with many exciting features that set it apart from other research FT-IRs. These include electronically coded beam windows with magnetic mount, an automated internal attenuator wheel and an 8-position validation wheel for standards and customer-specific filters. The unique Bruker Rocksolid™ interferometer and FM technology for simultaneous mid and far IR complete the INVENIO feature set.
About Bruker Corporation (NASDAQ: BRKR)
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research, clinical microbiology and molecular pathology research. For more information, please visit www.bruker.com
For more information on INVENIO, please visit: www.bruker.com/invenio
Media Contact:
Michael Mueller
Marketing Manager
Bruker Optics
T: +49 (7243) 504-2652
E: michael.mueller@bruker.com
Investor Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663-3660, ext. 1479
E: miroslava.minkova@bruker.com
Record changed: 2023-06-05 |
Advertisement

More documents for Bruker (Group)
- [1] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
- [2] Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA....
- [3] Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA....
- [4] Bruker Corporation. (5/8/23). "Press Release: Bruker Announces Acquisition of Zontal to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions". Billerica, MA....
- [5] Berkeley Lights, Inc.. (3/21/23). "Press Release: Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company". Emeryville, CA....
- [6] Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg....
- [7] Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne....
- [8] Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA....
- [9] Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA....
- [10] Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top